Peroxitech Therapeutics
Latest round
- Series A
Last raised
- Dec 2022
Total raised
- $25M
Investors
- 1
About Peroxitech Therapeutics
Based in Pennsylvania, US, and founded by Aron Fisher, Sheldon I., doing business as Peroxitech Therapeutics is a biopharmaceutical company that develops PIP-2 to repair and reverse acute lung injury (ALI) by addressing the cytokine storm cascade pathway. The company creates biopharmaceuticals based on its lead molecule, PIP-2, which helps to reduce reactive oxygen species (ROS) buildup in the lungs resulting from respiratory failure with hypoxemia and tissue acidosis, as well as to treat acute lung injury.
Who invested in Peroxitech Therapeutics
1 investor across 1 round
See all investors in Peroxitech Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Dec 13, 2022
Amount
$25M
Investors
Questions about Peroxitech Therapeutics
Who invested in Peroxitech Therapeutics?
Peroxitech Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Peroxitech Therapeutics raised?
Peroxitech Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Peroxitech Therapeutics last raise money?
Peroxitech Therapeutics's most recent round on record is a Series A, in Dec 2022.
What does Peroxitech Therapeutics do?
Based in Pennsylvania, US, and founded by Aron Fisher, Sheldon I.
Where is Peroxitech Therapeutics headquartered?
Peroxitech Therapeutics is headquartered in Philadelphia, US.
Which VCs invest in companies like Peroxitech Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Peroxitech Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Peroxitech Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.